M. Rahal
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
-
- Viral-associated cancers and disorders
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Papers in
- Co-authors
- Esteban Cvitkovic (4 shared papers)M. Bachouchi (4 shared papers)P. Wibault (4 shared papers)P. Armand (3 shared papers)Hamouda Boussen (3 shared papers)G Schwaab (3 shared papers)N. Azli (3 shared papers)Irfan Maghfoor (4 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Bone Marrow Transplantation (4 papers)International Orthopaedics (2 papers)Annals of Oncology (2 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- Saudi ArabiaLebanonFrance
In The Last Decade
M. Rahal
23 papers receiving 285 citations
Peers
Comparison fields: 5 of 50
- Otorhinolaryngology 138
- Oncology 171
- Pathology and Forensic Medicine 79
- Surgery 101
- Neurology 30
Countries citing papers authored by M. Rahal
This map shows the geographic impact of M. Rahal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Rahal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Rahal more than expected).
Fields of papers citing papers by M. Rahal
This network shows the impact of papers produced by M. Rahal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Rahal. The network helps show where M. Rahal may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Rahal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 93 | |
| 2 | 1992 | 29 | |
| 3 | 2006 | 27 | |
| 4 | 1997 | 23 | |
| 5 | Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type. | 2006 | 19 |
| 6 | 1990 | 18 | |
| 7 | 2007 | 18 | |
| 8 | 2009 | 14 | |
| 9 | 2000 | 10 | |
| 10 | 2020 | 8 | |
| 11 | 2021 | 7 | |
| 12 | 2008 | 5 | |
| 13 | 2004 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2018 | 4 | |
| 16 | 2022 | 2 | |
| 17 | 2003 | 2 | |
| 18 | 2019 | 2 | |
| 19 | 2019 | 1 | |
| 20 | 2004 | 1 |
About M. Rahal
M. Rahal is a scholar working on Oncology, Surgery, Pathology and Forensic Medicine, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 295 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (6 papers), Cancer Treatment and Pharmacology (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Head and Neck Cancer Studies (4 papers), Cancer Diagnosis and Treatment (4 papers), Breast Cancer Treatment Studies (3 papers), Shoulder Injury and Treatment (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Otorhinolaryngology (138 citations), Oncology (171 citations), Pathology and Forensic Medicine (79 citations), Surgery (101 citations) and Neurology (30 citations). M. Rahal has collaborated with scholars based in Saudi Arabia, Lebanon and France. Frequent co-authors include Esteban Cvitkovic, M. Bachouchi, P. Wibault, P. Armand, Hamouda Boussen, G Schwaab, N. Azli, Irfan Maghfoor, Amr El Weshi and Saad Akhtar. Their work appears in journals such as Journal of Clinical Oncology, Bone Marrow Transplantation, International Orthopaedics, Annals of Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.